Skip to main content

Table 2 Blood pressure characteristics at baseline for the total study population and stratified for reaching the blood pressure treatment target goal

From: Association of blood pressure with decline in renal function and time until the start of renal replacement therapy in pre-dialysis patients: a cohort study

 

All

n = 508

Below targetΔ

n = 58

Above targetΔ

n = 450

Systolic blood pressure (mmHg)

152 ± 27

114 ± 12

157 ± 25

Diastolic blood pressure (mmHg)

83 ± 14

68 ± 8

85 ± 13

Anti-hypertensive drug types (%)

   

   ACE-inhibitor

43

60

40

   Angiotensin II-inhibitor

20

10

21

   Beta-blocker

39

31

40

   Calcium antagonist

45

22

48

   Diuretics

48

52

48

   Other*

14

7

15

Number of anti-hypertensive drug types (%)

   

   0

8

9

8

   1

26

35

24

   2

28

33

28

   ≥ 3

38

23

40

  1. Systolic (SBP) and diastolic blood pressure (DBP) are presented as mean ± standard deviation (SD).
  2. Δ Below the target was defined as SBP < 130 and DBP < 80 mmHg and above the target as SBP ≥ 130 and/or DBP ≥ 80 mmHg. * Defined as the prescription of alpha blocker, vasodilator, and/or central working agent.